Seasoned finance executive and investor focused on middle-market private equity, operational value creation and board-level governance. Carl Amos Johnson brings multi-decade experience leading deal teams, structuring leveraged buyouts and executing portfolio transformations across industrials and TMT sectors. Known for hands-on operational oversight, strategic cost optimization and bolt-on M&A to drive EBITDA expansion, he frequently serves on portfolio company boards and sponsors exit processes for strategic and financial buyers. Background blends investment banking and operational leadership with experience raising institutional capital and managing LP relationships. Market-relevant profile: experienced sponsor with deep transaction experience, operational emphasis and a track record of positioning businesses for strategic sale or recapitalization.
Seasoned finance executive and investor focused on middle-market private equity, operational value creation and board-level governance. Carl Amos Johnson brings multi-decade experience leading deal teams, structuring leveraged buyouts and executing portfolio transformations across industrials and TMT sectors. Known for hands-on operational oversight, strategic cost optimization and bolt-on M&A to drive EBITDA expansion, he frequently serves on portfolio company boards and sponsors exit processes for strategic and financial buyers. Background blends investment banking and operational leadership with experience raising institutional capital and managing LP relationships. Market-relevant profile: experienced sponsor with deep transaction experience, operational emphasis and a track record of positioning businesses for strategic sale or recapitalization.
Targets control-oriented middle-market investments where operational redesign and bolt-on M&A can materially increase EBITDA and enterprise value. Employs a hands-on sponsor approach combining leveraged buyout structuring with active board governance, disciplined cost optimization, and strategic add-on consolidation. Capital allocation prioritizes companies with stable cash flows, clear margin-improvement levers and scalable platforms in industrials and TMT, with 3–7 year value-creation horizons geared to strategic sale or recapitalization. Underwriting emphasizes conservative leverage, scenario-driven downside protection and management alignment through equity incentives and governance covenants.
Targets control-oriented middle-market investments where operational redesign and bolt-on M&A can materially increase EBITDA and enterprise value. Employs a hands-on sponsor approach combining leveraged buyout structuring with active board governance, disciplined cost optimization, and strategic add-on consolidation. Capital allocation prioritizes companies with stable cash flows, clear margin-improvement levers and scalable platforms in industrials and TMT, with 3–7 year value-creation horizons geared to strategic sale or recapitalization. Underwriting emphasizes conservative leverage, scenario-driven downside protection and management alignment through equity incentives and governance covenants.
| Trades 333 | Longs Won 239/333 71% | Profit Factor 5.93 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $413,991.07 |
| Average Win $134,469.14 | Best Trade (Oct 15) $5.06M | Sharpe Ratio -11.27 |
| Average Loss -$57,647.09 | Worst Trade (Oct 14) -$2.09M | Z-Score 3.74 (99.98%) |
| Commissions $0 | Avg. Trade Length 1y 1w 6d | Expectancy $80,238.14 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,891 | 3,502 | 3,113 | 2,724 | 2,335 | 1,946 | 1,556 | 1,167 | 778 | 389 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 6,069 | $1.48M | $2.09M | - | $609,028.96 | 41.13% | +0.399% |
ABBV AbbVie Inc. | 2,743 | $575,233.58 | $785,883.21 | - | $210,649.63 | 36.62% | +1.067% |
ABT Abbott Laboratories | 2,746 | $364,256.75 | $286,792.24 | - | -$77,464.51 | -21.27% | +1.428% |
ADP Automatic Data Processing Inc. | 3,109 | $949,465.17 | $896,511.24 | - | -$52,953.93 | -5.58% | +2.868% |
AMGN Amgen Inc. | 671 | $219,625 | $295,890.87 | - | $76,265.87 | 34.73% | +3.487% |
AMZN Amazon.com Inc | 1,430 | $313,727.63 | $364,063.7 | - | $50,336.07 | 16.04% | +0.201% |
AVGO Broadcom Inc. | 745 | $206,049.6 | $253,173.35 | - | $47,123.75 | 22.87% | -1.854% |
BND Vanguard Total Bond Market Index Fund | 39,645 | $2.85M | $2.81M | - | -$46,804.44 | -1.64% | +0.611% |
BNDX Vanguard Total International Bond ETF | 295,212 | $14.48M | $13.93M | - | -$546,102.72 | -3.77% | +0.308% |
BRK-B Berkshire Hathaway Inc. | 800 | $362,623.9 | $422,800 | - | $60,176.1 | 16.59% | +0.408% |
BRW Saba Capital Income & Opportunities Fund | 11,532 | $87,874 | $68,154.12 | - | -$19,719.88 | -22.44% | +1.372% |
CAT Caterpillar Inc. | 274 | $291,783 | $199,732.3 | - | -$92,050.7 | -31.55% | -2.674% |
CVX Chevron Corporation | 1,098 | $224,223 | $240,829.83 | - | $16,606.83 | 7.41% | -1.218% |
CW Curtiss-Wright Corporation | 926 | $328,610 | $458,207.95 | - | $129,597.95 | 39.44% | -1.13% |
DDS Dillard's Inc. | 514 | $214,765 | $340,437.62 | - | $125,672.62 | 58.52% | +1.067% |
DFAT Dimensional US Targeted Value ETF | 33,951 | $1.89M | $2.3M | - | $414,711.18 | 21.95% | +1.035% |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 5,509 | $202,952 | $201,243.77 | - | -$1,708.23 | -0.84% | -0.137% |
DFIP Dimensional Inflation-Protected Securities ETF | 78,786 | $3.2M | $3.12M | - | -$79,150.19 | -2.48% | +0.585% |
DFUV Dimensional US Marketwide Value ETF | 6,544 | $267,780.81 | $366,889.36 | - | $99,108.55 | 37.01% | +0.565% |
DLS WisdomTree International SmallCap Dividend Fund | 40,874 | $2.57M | $3.49M | - | $914,935.78 | 35.56% | -0.321% |